305 related articles for article (PubMed ID: 15916700)
41. Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD: an event-related potential study using the Attention Network Test.
Kratz O; Studer P; Baack J; Malcherek S; Erbe K; Moll GH; Heinrich H
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):81-9. PubMed ID: 22227291
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.
Wigal SB; Gupta S; Heverin E; Starr HL
J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):255-63. PubMed ID: 21663428
[TBL] [Abstract][Full Text] [Related]
43. Effects of long-acting methylphenidate in adults with attention deficit hyperactivity disorder: a study with paired-pulse transcranial magnetic stimulation.
Schneider MK; Retz W; Gougleris G; Verhoeven WM; Tulen JH; Rösler M
Neuropsychobiology; 2011; 64(4):195-201. PubMed ID: 21912187
[TBL] [Abstract][Full Text] [Related]
44. Effects of perinatal methylphenidate (MPH) treatment in male and female Sprague-Dawley offspring.
Panos JJ; Law CD; Ferguson SA
Neurotoxicol Teratol; 2014; 42():9-16. PubMed ID: 24444667
[TBL] [Abstract][Full Text] [Related]
45. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children].
Pan XX; Ma HW; Wan B; Dai XM
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):471-4. PubMed ID: 18706164
[TBL] [Abstract][Full Text] [Related]
46. Characterization of anxiety-related responses in male rats following prolonged exposure to therapeutic doses of oral methylphenidate.
Britton GB; Bethancourt JA
Pharmacol Biochem Behav; 2009 Oct; 93(4):451-9. PubMed ID: 19540871
[TBL] [Abstract][Full Text] [Related]
47. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD.
Collins SL; Levin FR; Foltin RW; Kleber HD; Evans SM
Drug Alcohol Depend; 2006 Apr; 82(2):158-67. PubMed ID: 16213109
[TBL] [Abstract][Full Text] [Related]
48. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
[TBL] [Abstract][Full Text] [Related]
49. Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.
Brennan AR; Arnsten AF
Ann N Y Acad Sci; 2008; 1129():236-45. PubMed ID: 18591484
[TBL] [Abstract][Full Text] [Related]
50. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
51. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
[TBL] [Abstract][Full Text] [Related]
52. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
Huang YS; Chao CC; Wu YY; Chen YY; Chen CK
Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588
[TBL] [Abstract][Full Text] [Related]
53. Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder.
Kent JD; Blader JC; Koplewicz HS; Abikoff H; Foley CA
Pediatrics; 1995 Aug; 96(2 Pt 1):320-5. PubMed ID: 7630692
[TBL] [Abstract][Full Text] [Related]
54. Methylphenidate Dose-Dependently Affects Aggression and Improves Fear Extinction and Anxiety in BALB/cJ Mice.
Jager A; Kanters D; Geers F; Buitelaar JK; Kozicz T; Glennon JC
Front Psychiatry; 2019; 10():768. PubMed ID: 31708820
[TBL] [Abstract][Full Text] [Related]
55. The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex.
Spencer RC; Devilbiss DM; Berridge CW
Biol Psychiatry; 2015 Jun; 77(11):940-50. PubMed ID: 25499957
[TBL] [Abstract][Full Text] [Related]
56. Methylphenidate Treatment of Cognitive Dysfunction in Adults After Mild to Moderate Traumatic Brain Injury: Rationale, Efficacy, and Neural Mechanisms.
Levin H; Troyanskaya M; Petrie J; Wilde EA; Hunter JV; Abildskov TJ; Scheibel RS
Front Neurol; 2019; 10():925. PubMed ID: 31572283
[TBL] [Abstract][Full Text] [Related]
57. Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood.
Andersen SL; Sonntag KC
Front Synaptic Neurosci; 2014; 6():1. PubMed ID: 24478696
[TBL] [Abstract][Full Text] [Related]
58. The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.
Arnsten AF
J Pediatr; 2009 May; 154(5):I-S43. PubMed ID: 20596295
[TBL] [Abstract][Full Text] [Related]
59. Methylphenidate alleviates cognitive dysfunction from early Mn exposure: Role of catecholaminergic receptors.
Beaudin SA; Howard S; Santiago N; Strupp BJ; Smith DR
bioRxiv; 2023 Oct; ():. PubMed ID: 37873333
[TBL] [Abstract][Full Text] [Related]
60. The effects of methylphenidate on cognitive performance of healthy male rats.
Rostron CL; Kaplan E; Gaeta V; Nigriello R; Dommett EJ
Front Neurosci; 2013; 7():97. PubMed ID: 23781167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
